Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.

Freeman SR, Drake AL, Heilig LF, Graber M, McNealy K, Schilling LM, Dellavalle RP.

J Natl Cancer Inst. 2006 Nov 1;98(21):1538-46. Review.

PMID:
17077356
2.

Statins and fibrates for preventing melanoma.

Dellavalle RP, Drake A, Graber M, Heilig LF, Hester EJ, Johnson KR, McNealy K, Schilling L.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003697. Review.

PMID:
16235336
3.

Differential associations of statin and fibrate treatment with carotid arterial remodeling.

Chironi G, Simon A, Gariepy J, Balice M, Del-Pino M, Levenson J.

Am J Hypertens. 2005 Nov;18(11):1476-81.

PMID:
16280285
4.
5.
6.

Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P.

Arch Intern Med. 2003 Mar 24;163(6):669-76. Review.

PMID:
12639199
7.

[Atherosclerosis in light of the evidence from large statin trials].

Cortese C, Bernardini S, Motti C.

Ann Ital Med Int. 2000 Jan-Mar;15(1):103-7. Review. Italian.

PMID:
10842899
8.

An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).

Smith DG, McBurney CR.

Pharmacoeconomics. 2003;21 Suppl 1:13-23.

PMID:
12648031
9.

Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia.

Athyros VG, Papageorgiou AA, Athyrou VV, Demitriadis DS, Pehlivanidis AN, Kontopoulos AG.

J Cardiovasc Risk. 2002 Feb;9(1):33-9.

PMID:
11984215
10.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-Rubió P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
11.

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2012 Oct 11;11:125. doi: 10.1186/1475-2840-11-125. Review.

12.

Statins and stroke: current clinical practice.

Castilla-Guerra L, Espino-Montoro A, Fernandez Moreno Mdel C, López-Chozas JM, Jimérnez MD.

Stroke. 2006 May;37(5):1153. Epub 2006 Mar 23. No abstract available.

PMID:
16556875
13.

[Statins: similarities and differences in the pharmacological, clinical and laboratory aspects].

Motti C, Gnasso A, Cortese C.

Ann Ital Med Int. 2000 Jan-Mar;15(1):96-102. Review. Italian.

PMID:
10842898
14.

Statins in children: what do we know and what do we need to do?

Black DM.

Curr Atheroscler Rep. 2001 Jan;3(1):29-34. Review.

PMID:
11123845
15.

Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.

Choudhry NK, Levin R, Winkelmayer WC.

Heart. 2007 Aug;93(8):945-51. Epub 2007 Mar 7.

16.

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.

Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE.

BMC Med. 2007 Jul 19;5:20.

17.

Statin trials in progress: unanswered questions.

Davidson MH.

Curr Atheroscler Rep. 2001 Jan;3(1):9-13. Review.

PMID:
11123842
18.

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Zhou Z, Rahme E, Abrahamowicz M, Tu JV, Eisenberg MJ, Humphries K, Austin PC, Pilote L.

CMAJ. 2005 Apr 26;172(9):1187-94.

19.

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.

Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, Lafrance JP, Levy A, Garg AX, Ernst P; Canadian Network for Observational Drug Effect Studies.

BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.

20.

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D.

J Am Coll Cardiol. 2008 Nov 25;52(22):1769-81. doi: 10.1016/j.jacc.2008.08.039.

Supplemental Content

Support Center